102 related articles for article (PubMed ID: 15857754)
1. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells.
Laïos I; Journé F; Nonclercq D; Vidal DS; Toillon RA; Laurent G; Leclercq G
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):347-59. PubMed ID: 15857754
[TBL] [Abstract][Full Text] [Related]
2. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
3. Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment.
Seo HS; Journé F; Larsimont D; Sotiriou C; Leclercq G
Steroids; 2003 Mar; 68(3):257-69. PubMed ID: 12628689
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens.
Laïos I; Journe F; Laurent G; Nonclercq D; Toillon RA; Seo HS; Leclercq G
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):207-21. PubMed ID: 14672741
[TBL] [Abstract][Full Text] [Related]
5. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
El Khissiin A; Journé F; Laïos I; Seo HS; Leclercq G
Steroids; 2000 Dec; 65(12):903-13. PubMed ID: 11077089
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.
Nonclercq D; Journé F; Body JJ; Leclercq G; Laurent G
Mol Cell Endocrinol; 2004 Nov; 227(1-2):53-65. PubMed ID: 15501584
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.
Fan M; Nakshatri H; Nephew KP
Mol Endocrinol; 2004 Nov; 18(11):2603-15. PubMed ID: 15284335
[TBL] [Abstract][Full Text] [Related]
9. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells.
Seo HS; Leclercq G
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):109-23. PubMed ID: 11867270
[TBL] [Abstract][Full Text] [Related]
11. A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
Kretzer NM; Cherian MT; Mao C; Aninye IO; Reynolds PD; Schiff R; Hergenrother PJ; Nordeen SK; Wilson EM; Shapiro DJ
J Biol Chem; 2010 Dec; 285(53):41863-73. PubMed ID: 21041310
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
[TBL] [Abstract][Full Text] [Related]
13. Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells.
Journé F; Dumon JC; Kheddoumi N; Fox J; Laïos I; Leclercq G; Body JJ
Bone; 2004 Aug; 35(2):479-88. PubMed ID: 15268900
[TBL] [Abstract][Full Text] [Related]
14. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
[TBL] [Abstract][Full Text] [Related]
15. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner.
Yi JM; Kwon HY; Cho JY; Lee YJ
Biochem Biophys Res Commun; 2009 Jan; 378(4):842-6. PubMed ID: 19084502
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.
Tschugguel W; Dietrich W; Zhegu Z; Stonek F; Kolbus A; Huber JC
J Clin Endocrinol Metab; 2003 May; 88(5):2281-7. PubMed ID: 12727987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
